Published in:
01-06-2010 | Original Paper
Gene–environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population
Published in: Journal of Cancer Research and Clinical Oncology | Issue 6/2010
Login to get accessAbstract
Purpose
Genetic risk to tobacco related cancers are associated with polymorphisms in CYP1A1 and GST, which are involved in the metabolic activation and detoxification of carcinogens. The genetic variations in these drug-metabolizing enzymes may alter the susceptibility to UADT cancers triggered by environmental exposures. The hospital-based case–control study evaluated the impact of combined CYP1A1 MspI and GST (M1 & T1) polymorphisms among the individuals exposed to environmental risk factors as modulators in the risk of UADT cancers in Tamilians, a population of south India.
Methods
The unrelated histopathologically confirmed 408 cases and 220 population-based controls matched by age and gender were genotyped for CYP1A1 MspI, GSTM1 and GSTT1 polymorphisms using PCR based methods. To investigate the potential gene–environment interactions, analyses were carried out stratifying by smoking and tobacco chewing status using SPSS software.
Results
The combination of genes and environment interactions by stratified analyses revealed significant interactions among the habitual tobacco smokers (CYP1A1 MspI & GSTM1 null: OR 14.06; 95% CI 3.90–50.68, CYP1A1 MspI & GSTT1 null: OR 33.28; 95% CI 4.24–261.19) and tobacco chewers (CYP1A1 MspI & GSTM1 null: OR 20.51; 95% CI 6.77–62.13, CYP1A1 MspI & GSTT1 null: OR 79.35; 95% CI 10.40–605.55) on the multiplicative scale.
Conclusion
Our findings have indicated that the individuals polymorphic for CYP1A1 MspI either with GSTM1 null or with GSTT1 null genotypes revealed an increased risk for UADT cancers than that ascribed to a single susceptible gene among the tobacco users in the population [single gene risk among smokers and chewers, respectively, for CYP1A1 MspI (OR 6.43; 95% CI 3.69–11.21); (OR 10.24; 95% CI 5.95–17.60), GSTM1*0 (OR 3.77; 95% CI 1.94–7.37); (OR 7.97 95% CI 4.10–15.76) and GSTT1*0 (OR 6.95 95% CI 2.88–16.77); (OR 25.83 95% CI 7.78–85.76).